🇺🇸 FDA
Patent

US 8354411

1-phenyl-3-pyrazolylpyridazin-4(1H)-one compound

granted A61KA61K9/2059A61P

Quick answer

US patent 8354411 (1-phenyl-3-pyrazolylpyridazin-4(1H)-one compound) held by Takeda Pharmaceutical Company Limited expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K9/2059, A61P, A61P25/00, A61P25/14